Ionis Pharmaceuticals, Inc. Inventory, Work in Process, Gross
Ionis Pharmaceuticals, Inc. (IONS) had Inventory, Work in Process, Gross of $8.74 million as of 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2025-04-30
- 2025-03-31: Inventory, Work in Process, Gross $8.74M.
- 2024-12-31: Inventory, Work in Process, Gross $6.68M.
- 2024-09-30: Inventory, Work in Process, Gross $6.65M.
- 2024-06-30: Inventory, Work in Process, Gross $3.61M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2025-03-31 | $8.74M 10-Q · filed 2025-04-30 |
| 2024-12-31 | $6.68M 10-Q · filed 2025-04-30 |
| 2024-09-30 | $6.65M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.61M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $6.04M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $5.48M 10-K · filed 2025-02-19 |
| 2023-09-30 | $2.65M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.09M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.84M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $2.11M 10-K · filed 2024-02-21 |
| 2022-09-30 | $3.74M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.93M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $5.64M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $5.77M 10-K · filed 2023-02-22 |
| 2021-09-30 | $6.18M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $954.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | $2.10M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $2.25M 10-K · filed 2022-02-25 |
| 2020-09-30 | $3.35M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $3.47M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.65M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $2.04M 10-K · filed 2021-02-24 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |